197 related articles for article (PubMed ID: 2085982)
1. Fosfomycin trometamol versus amoxycillin--single-dose multicenter study of urinary tract infections.
Neu HC
Chemotherapy; 1990; 36 Suppl 1():19-23. PubMed ID: 2085982
[TBL] [Abstract][Full Text] [Related]
2. General practitioner study: fosfomycin trometamol versus amoxycillin clavulanate in acute urinary tract infections.
Cooper J; Raeburn AL; Brumfitt W; Hamilton-Miller JM
Chemotherapy; 1990; 36 Suppl 1():24-6. PubMed ID: 2085984
[TBL] [Abstract][Full Text] [Related]
3. Fosfomycin trometamol in a single dose versus norfloxacin for seven days in the treatment of uncomplicated urinary infections in general practice.
Boerema JB; Willems FT
Infection; 1990; 18 Suppl 2():S80-8. PubMed ID: 2286467
[TBL] [Abstract][Full Text] [Related]
4. Fosfomycin trometamol versus ofloxacin/co-trimoxazole as single dose therapy of acute uncomplicated urinary tract infection in females: a multicentre study.
Naber KG; Thyroff-Friesinger U
Infection; 1990; 18 Suppl 2():S70-6. PubMed ID: 2286465
[TBL] [Abstract][Full Text] [Related]
5. Single-dose treatment of lower urinary tract infections with fosfomycin trometamol: preliminary experiences.
Arione R; Fontana P
Chemioterapia; 1987 Aug; 6(4):295-8. PubMed ID: 3308148
[TBL] [Abstract][Full Text] [Related]
6. A comparative double-blind randomised study of single dose fosfomycin trometamol with trimethoprim in the treatment of urinary tract infections in general practice.
Harvard Davis R; O'Dowd TC; Holmes W; Smail J; Slack RC
Chemotherapy; 1990; 36 Suppl 1():34-6. PubMed ID: 2085987
[TBL] [Abstract][Full Text] [Related]
7. Single-dose fosfomycin trometamol (Monuril) versus multiple-dose norfloxacin: results of a multicenter study in females with uncomplicated lower urinary tract infections.
de Jong Z; Pontonnier F; Plante P
Urol Int; 1991; 46(4):344-8. PubMed ID: 1926651
[TBL] [Abstract][Full Text] [Related]
8. Spectrum and susceptibility of pathogens causing acute uncomplicated lower UTI in females and its correlation to bacteriologic outcome after single dose therapy with fosfomycin trometamol versus ofloxacin/co-trimoxazole.
Naber KG; Thyroff-Friesinger U
Infection; 1992; 20 Suppl 4():S296-301. PubMed ID: 1294521
[TBL] [Abstract][Full Text] [Related]
9. Single-dose fosfomycin trometamol versus 5-day cephalexin regimen for treatment of uncomplicated lower urinary tract infections in women.
Elhanan G; Tabenkin H; Yahalom R; Raz R
Antimicrob Agents Chemother; 1994 Nov; 38(11):2612-4. PubMed ID: 7872756
[TBL] [Abstract][Full Text] [Related]
10. A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women.
Minassian MA; Lewis DA; Chattopadhyay D; Bovill B; Duckworth GJ; Williams JD
Int J Antimicrob Agents; 1998 Apr; 10(1):39-47. PubMed ID: 9624542
[TBL] [Abstract][Full Text] [Related]
11. Single dose fosfomycin trometamol versus multiple dose norfloxacin over three days for uncomplicated UTI in general practice.
Reynaert J; Van Eyck D; Vandepitte J
Infection; 1990; 18 Suppl 2():S77-9. PubMed ID: 2286466
[TBL] [Abstract][Full Text] [Related]
12. [Fosfomycin: an underrated antibiotic for urinary tract infections due to Escherichia coli].
Garau M; Latorre A; Alonso-Sanz M
Enferm Infecc Microbiol Clin; 2001 Dec; 19(10):462-6. PubMed ID: 11844449
[TBL] [Abstract][Full Text] [Related]
13. Single dose and conventional treatment for acute bacterial and non-bacterial dysuria and frequency in general practice.
Cooper J; Raeburn A; Brumfitt W; Hamilton-Miller JM
Infection; 1990; 18(2):65-9. PubMed ID: 2185155
[TBL] [Abstract][Full Text] [Related]
14. Fosfomycin trometamol in a single dose versus seven days nitrofurantoin in the treatment of acute uncomplicated urinary tract infections in women.
Van Pienbroek E; Hermans J; Kaptein AA; Mulder JD
Pharm World Sci; 1993 Dec; 15(6):257-62. PubMed ID: 8298585
[TBL] [Abstract][Full Text] [Related]
15. Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).
Ten Doesschate T; van Mens SP; van Nieuwkoop C; Geerlings SE; Hoepelman AIM; Bonten MJM
BMC Infect Dis; 2018 Dec; 18(1):626. PubMed ID: 30518334
[TBL] [Abstract][Full Text] [Related]
16. Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria.
Keating GM
Drugs; 2013 Nov; 73(17):1951-66. PubMed ID: 24202878
[TBL] [Abstract][Full Text] [Related]
17. Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study.
Rudenko N; Dorofeyev A
Arzneimittelforschung; 2005; 55(7):420-7. PubMed ID: 16080282
[TBL] [Abstract][Full Text] [Related]
18. Fosfomycin trometamol versus norfloxacin in the treatment of uncomplicated lower urinary tract infections of the elderly.
Ferraro G; Ambrosi G; Bucci L; Palmieri R; Palmieri G
Chemotherapy; 1990; 36 Suppl 1():46-9. PubMed ID: 2085990
[TBL] [Abstract][Full Text] [Related]
19. Fosfomycin-trometamol for Urinary Tract Infections in Kidney Transplant Recipients.
Ten Doesschate T; van Werkhoven H; Meijvis S; Stalenhoef J; van Zuilen A; de Vries A; Bonten M
Transplantation; 2019 Jun; 103(6):1272-1276. PubMed ID: 30130327
[TBL] [Abstract][Full Text] [Related]
20. In-vitro susceptibility of quinolone-resistant clinical isolates of Escherichia coli to fosfomycin trometamol.
Ungheri D; Albini E; Belluco G
J Chemother; 2002 Jun; 14(3):237-40. PubMed ID: 12120876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
